Search / Trial NCT06612996

Intravenous Tramadol and Magnesium Sulphate for Prevention of Shivering

Launched by AL-AZHAR UNIVERSITY · Sep 23, 2024

Trial Information

Current as of December 21, 2024

Not yet recruiting

Keywords

Tramadol Magnesium Sulphate Shivering

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - American Society of Anesthesiologists (ASA) I and II physical status undergoing an elective surgery under spinal anesthesia.
  • Exclusion Criteria:
  • history of uncontrolled comorbidities, cardiac, respiratory, renal or hepatic disease, patients who had allergy to any medication in the study, contraindications to spinal anesthesia (coagulation disorder, infection at site of puncture, raised intracranial tension or any spine deformity), fever \>38 Celsius or less than 36 Celsius, body mass index more than 35 and who has history of alcohol intake

About Al Azhar University

Al-Azhar University, a prestigious institution in Egypt, is dedicated to advancing medical research and education through rigorous clinical trials. With a strong emphasis on ethical standards and scientific integrity, the university aims to contribute to the development of innovative therapies and healthcare solutions. By fostering collaboration among researchers, healthcare professionals, and academic experts, Al-Azhar University positions itself as a leading sponsor in clinical research, committed to improving patient outcomes and enhancing the understanding of various medical conditions.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0